Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant in Excessive Daytime Sleepiness in Parkinson's Disease
NCT00642928Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Oct 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pitolisant in Excessive Daytime Sleepiness (EDS), sponsored by Bioprojet. Started Oct 2007; status: completed.
02
Drugs
pitolisant
03
Conditions
Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on NCT00642928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642928.